Investigating the potential of using nanotechnology for targeted drug delivery in cancer treatment.

Thesis Abstract

Abstract
Cancer remains a prevalent and challenging disease worldwide, necessitating the continual advancement of treatment modalities to improve patient outcomes. Nanotechnology has emerged as a promising approach for enhancing drug delivery to tumor sites, thereby increasing treatment efficacy while minimizing systemic toxicity. This thesis investigates the potential of utilizing nanotechnology for targeted drug delivery in cancer treatment. The study encompasses a comprehensive review of the literature on nanotechnology applications in oncology, focusing on the development of nanocarriers for delivering chemotherapeutic agents specifically to cancer cells. The research methodology involves in vitro and in vivo experiments to evaluate the efficacy and safety of nanotechnology-based drug delivery systems in various cancer models. The findings of this research provide insights into the feasibility and effectiveness of using nanotechnology for targeted drug delivery in cancer treatment. The discussion highlights the implications of these findings for clinical practice and the potential future directions for research in this field. Ultimately, this thesis contributes to advancing our understanding of how nanotechnology can be harnessed to improve cancer treatment outcomes through precise and targeted drug delivery mechanisms.